ENOS Antikörper (pThr495) (PE)
Kurzübersicht für ENOS Antikörper (pThr495) (PE) (ABIN6988715)
Target
Alle ENOS (NOS3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pThr495
-
Kreuzreaktivität
- Human, Maus
-
Homologie
- Rat,Dog,Cow,Sheep,Pig,Rabbit,Guinea Pig
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic phosphopeptide derived from human eNOS around the phosphorylation site of Thr495
-
Isotyp
- IgG
-
-
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (pSer1177) antibody
NOS3 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1105-1202) antibodyNOS3 Reaktivität: Human, Ratte, Maus WB, ELISA, IF (cc), IF (p), FACS, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1156-1183) antibodyNOS3 Reaktivität: Human WB, IF, FACS Wirt: Kaninchen Polyclonal RB29786 unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 48-75), (N-Term) antibodyNOS3 Reaktivität: Human IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB18211 unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (pSer1177) antibodyNOS3 Reaktivität: Human, Ratte, Maus WB, ELISA, IF (cc), IF (p), FACS, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (C-Term) antibodyNOS3 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1-120) antibodyNOS3 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 1156-1183) antibodyNOS3 Reaktivität: Human WB, ELISA, IF, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 756-888) antibodyNOS3 Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3) (AA 61-160) antibodyNOS3 Reaktivität: Human WB, ELISA, PLA Wirt: Maus Monoclonal 1D12 unconjugated
-
-
Applikationshinweise
- FCM 1:20-100
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- ENOS (NOS3) (Nitric Oxide Synthase 3 (Endothelial Cell) (NOS3))
-
Andere Bezeichnung
- eNOS
-
Hintergrund
-
Synonyms: eNOS, ECNOS, Nitric oxide synthase, endothelial, Constitutive NOS, cNOS, EC-NOS, Endothelial NOS, NOS type III, NOSIII, NOS3
Background: Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets. Isoform eNOS13C: Lacks eNOS activity, dominant-negative form that may down-regulate eNOS activity by forming heterodimers with isoform 1.
-
Gen-ID
- 4846
-
UniProt
- P29474
-
Pathways
- ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Cellular Response to Molecule of Bacterial Origin, Myometrial Relaxation and Contraction, Signaling Events mediated by VEGFR1 and VEGFR2, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Target
-
